Probe Ordered Into India Patent For Roche’s Valcyte (India)
This article was originally published in PharmAsia News
Executive Summary
India's controller general ordered an investigation of a decision by the patent office in Chennai to grant F. Hoffman-LaRoche a patent for its Valcyte (valganciclovir hydrochloride) for HIV/AIDS infection developed during organ transplants. The patent office granted the patent to the Swiss drug maker without hearing opposition by a patient group, as required by law. A Mumbai lawyers group filed a pre-grant opposition last year, but the Chennai office granted the patent to Roche in September without a hearing on the group's filing. The group challenged the patent on grounds Roche relied on a pre-1995 molecule, and thus could not have received a patent under Indian law that says only post-2005 drugs are eligible for patent protection. (Click here for more
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.